797032-05-4 Usage
Uses
Used in Organic Synthesis:
Ethyl 3-nitropyridin-4-yl(cyclopropyl)carbamate is utilized as a key intermediate in organic synthesis for the creation of various complex organic molecules. Its unique structural features, including the nitro group and cyclopropylcarbamate moiety, facilitate its use in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Drug Development:
In the pharmaceutical industry, Ethyl 3-nitropyridin-4-yl(cyclopropyl)carbamate is employed as a precursor in the development of new drugs. Its potential biological activity, stemming from its structural components, makes it a candidate for further exploration in medicinal chemistry. Ethyl 3-nitropyridin-4-yl(cyclopropyl)carbamate may be modified or used as a building block to create novel therapeutic agents with specific pharmacological properties.
Used in Research and Testing:
Ethyl 3-nitropyridin-4-yl(cyclopropyl)carbamate serves as a valuable research tool in laboratories, where it is used to study the effects of its structural components on biological systems. This can aid in understanding the compound's interactions with biological targets and its potential applications in therapeutic interventions.
Check Digit Verification of cas no
The CAS Registry Mumber 797032-05-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,7,0,3 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 797032-05:
(8*7)+(7*9)+(6*7)+(5*0)+(4*3)+(3*2)+(2*0)+(1*5)=184
184 % 10 = 4
So 797032-05-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H13N3O4/c1-2-18-11(15)13(8-3-4-8)9-5-6-12-7-10(9)14(16)17/h5-8H,2-4H2,1H3
797032-05-4Relevant articles and documents
Development of an efficient and scalable process of a respiratory syncytial virus inhibitor
Provencal, David P.,Gesenberg, Kirsten D.,Wang, Hua,Escobar, Carlos,Wong, Henry,Brown, Matthew A.,Staab, Andrew J.,Pendri, Yadagiri R.
, p. 903 - 908 (2013/09/03)
An improved process has been developed for compound 1, a respiratory syncytial virus (RSV) inhibitor. This improved process is convergent, safe, efficient, and useful to prepare compound 1 in kilogram quantities.
